Durable complete response of advanced hepatocellular carcinoma using cannabis oil: a report of two cases

Rákkutatás · Hepatocellular carcinoma

The report documents durable complete regression of advanced hepatocellular carcinoma (HCC) following cannabis oil use in two patients, suggesting a potential anti‑tumor effect of cannabinoids.

Hepatocellular carcinoma (HCC) is a leading cause of cancer‑related mortality worldwide with a grim prognosis. Current treatment options for advanced HCC are limited, and a large proportion of patients is not amenable to any form of treatment, with best supportive care as the only remaining option. Meanwhile, the use of cannabis‑derived products is rising in oncological patients who are seeking symptom relief. Cannabinoids, similar to endogenous endocannabinoids, have shown promise in recent preclinical cancer research due to their ability to interact with various signaling pathways and molecular mechanisms of interest. In this report, we present two patients (A aged 82 and B 77, respectively) with advanced HCC with a high tumor burden who demonstrated durable and complete regression after use of cannabis oil (A 10% delta‑9‑tetrahydrocannabinol (THC) and 5% cannabidiol (CBD), two droplets sublingually three times daily and B 15% THC and 2% CBD, 5 droplets sublingually two times daily) for symptom relief. The observations in this report build on previous (pre)clinical research highlighting the potential anti‑tumor qualities of cannabinoids and stress the need for clinical trials investigating the anti‑tumor effects of cannabinoids in cancer patients.

The observations suggest that cannabis oil may exert an anti‑tumor effect in advanced HCC, a disease with limited therapeutic options, underscoring the importance of controlled clinical studies to evaluate efficacy and safety.

Bizonyítékszint: Klinikai vizsgálat. Formális klinikai vizsgálati eredmény.

Eredeti forrás

Kapcsolódó jelek